MedPath

Reconstruction of dorsal foot defects: Comparing Skin Substitutes with Natural Tissue Flaps

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2025/05/087166
Lead Sponsor
All india institute of medical sciences jodhpur
Brief Summary

A prospective randomized controlled trial will be conducted to compare the functional, aesthetic, and psychosocial outcomes of dermal substitutes versus free fasciocutaneous flaps in the reconstruction of dorsal foot defects. Patients will be randomly allocated into two groups using a computer-generated randomization sequence. Outcome measures will be assessed in the immediate postoperative period, at 3 weeks, and at monthly intervals for a total duration of 6 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
76
Inclusion Criteria

All patients undergoing dermal substitute application and free fasciocutaneous flaps for reconstruction of dorsal foot defects due to trauma ,infections post oncologic resection , diabetes and ulcers size more and 3cmsq and below 25cmsq.

Exclusion Criteria

Patients with peripheral vascular disease for limb defects , unfit for prolonged surgeries and patients with psychiatric disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess functional recovery and aesthetic outcome in immediate and late post- operative groups operative period in both the groupsImmediate , At 3 weeks and monthly for 6 months
Secondary Outcome Measures
NameTimeMethod
To evaluate healing time, sensation recovery, complication rates,duration of hospital stay and cost effectiveness in both the groupsImmediate , At 3 weeks and monthly for 6 months

Trial Locations

Locations (1)

All India Institute of Medical Sciences

🇮🇳

Jodhpur, RAJASTHAN, India

All India Institute of Medical Sciences
🇮🇳Jodhpur, RAJASTHAN, India
Dr Praveen Kumar N
Principal investigator
8792698650
praveenkumar19934@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.